Ae Wealth Management LLC Novo Cure LTD Transaction History

Ae Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	SELL	$75.08 - $121.99 $151,060 - $245,443	-2,012 Closed	0 $0
Q3 2021 Nov 01, 2021	SELL	$116.17 - $194.55 $184,477 - $308,945	-1,588 Reduced 44.11%	2,012 $234,000
Q2 2021 Jul 21, 2021	SELL	$130.4 - $225.58 $24,515 - $42,409	-188 Reduced 4.96%	3,600 $799,000
Q1 2021 Apr 27, 2021	SELL	$124.11 - $190.17 $846,802 - $1.3 Million	-6,823 Reduced 64.3%	3,788 $501,000
Q4 2020 Feb 01, 2021	BUY	$112.16 - $174.14 $943,602 - $1.47 Million	8,413 Added 382.76%	10,611 $1.84 Million
Q3 2020 Nov 06, 2020	SELL	$58.05 - $111.31 $83,069 - $159,284	-1,431 Reduced 39.43%	2,198 $245,000
Q2 2020 Aug 05, 2020	BUY	$57.2 - $74.41 $207,578 - $270,033	3,629 New	3,629 $215,000

272

77.2M

751K

293K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.64B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.